United Kingdom-Edinburgh: NSSCOVID-19 — Apheresis Convalescent Plasma

Type of document: Modification of a contract/concession during its term
Country: United Kingdom
OJEU Ref: (2020/S 118-287919/EN)
Nature of contract: Supply contract
Procedure: Award of a contract without prior publication
Type of bid required: Not applicable

Modification of a contract/concession during its term
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: Scottish National Blood Transfusion Service
Postal address: The Jack Copland Centre, 52 Research Avenue, Heriot-Watt Research Park
Town: Edinburgh
Postal code: EH14 4BE
Country: United Kingdom
Telephone: +44 1313145522
Email: gordon.dickson@nhs.net
Internet address(es):
Main address:
Address of the buyer profile:

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: NSSCOVID-19 — Apheresis Convalescent Plasma

Reference number: NSSCOVID-19-185
II.1.2) Main CPV code: 33141613
II.1.3) Type of contract: Supplies
II.2) Description
II.2.3) Place of performance
Nuts code:
II.2.4) Description of the procurement at the time of conclusion of the contract
This contract modification has been agreed between the supplier and the authority on behalf of NHS Scotland to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic.
This modification has been approved to maintain necessary supply and remove unnecessary disruption from the authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015.
II.2.7) Duration of the contract,framework agreement,dynamic purchasing system or concession
Duration in months:6
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure
IV.2) Administrative information
IV.2.1) Contract award notice concerning this contract
Notice number in the OJ S:2020/S 111-270692
Section V: Award of contract/concession
Contract No: NSS COVID 19 – 185
Title: NSSCOVID-19 — Apheresis Convalescent Plasma

V.2) Award of contract/concession
V.2.1) Date of conclusion of the contract/concession award decision:2020-05-27
V.2.2) Information about tenders
V.2.4) Information on value of the contract/lot/concession(at the time of conclusion of the contract;excluding VAT)

Section VI: Complementary information
VI.3) Additional information:
(SC Ref:623560)
VI.4) Procedures for review
VI.4.1) Review body
Official name: Sheriff Court House
Postal address: 27 Chambers Street
Town: Edinburgh
Postal code: EH1 1LN
Country: United Kingdom
Telephone: +44 1312252525
E-mail: edinburgh@scotcourts.gov.uk

VI.5) Date of dispatch of this notice:
2020-06-16

Section VII: Modifications to the contract/concession
VII.1) Description of the procurement after the modifications
VII.1.1) Main CPV code: 33141613
VII.1.3) Place of performance
Nuts code:
VII.1.4) Description of the procurement:
This contract modification has been agreed between the supplier and the authority on behalf of NHS Scotland to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic.
This modification has been approved to maintain necessary supply and remove unnecessary disruption from the authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015.
VII.1.5) Duration of the contract,framework agreement,dynamic purchasing system or concession
Duration in months:6
VII.1.6) Information on value of the contract/lot/concession(excluding VAT)
VII.2) Information about modifications VII.2.1) Description of the modifications
Nature and extent of the modifications(with indication of possible earlier changes to the contract):
Doctors in the UK would like to offer Convalescent Plasma as a potential treatment to Covid-19 patients. To allow this SNBTS will require additional harnesses to collect the volumes required.

VII.2.2) Reasons for modification
Need for modification brought about by circumstances which a diligent contracting authority/entity could not
foresee(Art.43(1)(c) of Directive 2014/23/EU, Art.72(1)(c) of Directive 2014/24/EU, Art.89(1)(c) of Directive 2014/25/EU)
Description of the economic or technical reasons and the inconvenience or duplication of cost preventing a
change of contractor:

VII.2.3) Increase in price